galactosamine has been researched along with costunolide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, Y; Guo, C; Shi, M; Wang, Y; Wei, Z; Yang, Z; Zhang, X; Zhao, L | 1 |
1 other study(ies) available for galactosamine and costunolide
Article | Year |
---|---|
Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Injections, Intraperitoneal; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Protective Agents; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |